<?xml version='1.0' encoding='utf-8'?>
<document id="17524944"><sentence text="Optimization of immunosuppressive drug monitoring in children." /><sentence text="The metabolism of drugs in children differs from adults, although pediatric pharmacokinetic (PK) studies remain scarce" /><sentence text=" Many of the drugs are metabolized by polymorphically expressed enzymes (cytochrome P450 [CYP450]; glucuronyl transferase [GT]) and/or transported by drug transporters (ABC and SLC families)" /><sentence text=" In children, there is added complexity because of the age dependency of drug metabolism" /><sentence text=" This review addresses the age dependency of drug metabolism in childhood on the basis of routine PK monitoring" /><sentence text="" /><sentence text="Standard pharmacokinetic studies in pediatric renal transplant recipients were analyzed to study drug-drug interactions between mycophenolic acid and cyclosporine on the one hand, and tacrolimus and sirolimus on the other hand"><entity charOffset="128-145" id="DDI-PubMed.17524944.s7.e0" text="mycophenolic acid" /><entity charOffset="150-162" id="DDI-PubMed.17524944.s7.e1" text="cyclosporine" /><entity charOffset="184-194" id="DDI-PubMed.17524944.s7.e2" text="tacrolimus" /><entity charOffset="199-208" id="DDI-PubMed.17524944.s7.e3" text="sirolimus" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e0" e2="DDI-PubMed.17524944.s7.e0" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e0" e2="DDI-PubMed.17524944.s7.e1" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e0" e2="DDI-PubMed.17524944.s7.e2" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e0" e2="DDI-PubMed.17524944.s7.e3" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e1" e2="DDI-PubMed.17524944.s7.e1" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e1" e2="DDI-PubMed.17524944.s7.e2" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e1" e2="DDI-PubMed.17524944.s7.e3" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e2" e2="DDI-PubMed.17524944.s7.e2" /><pair ddi="false" e1="DDI-PubMed.17524944.s7.e2" e2="DDI-PubMed.17524944.s7.e3" /></sentence><sentence text=" The exposure was compared with age" /><sentence text=" We also studied sirolimus metabolites, both by mass spectrometry as well as using human liver microsomes"><entity charOffset="17-26" id="DDI-PubMed.17524944.s9.e0" text="sirolimus" /></sentence><sentence text="" /><sentence text="We demonstrated age dependency for MPA exposure" /><sentence text=" Independent of the concomitant medication, infants required approximately twice as much drug for the same exposure" /><sentence text=" The drug-drug interaction between sirolimus and tacrolimus demonstrated age dependency"><entity charOffset="35-44" id="DDI-PubMed.17524944.s13.e0" text="sirolimus" /><entity charOffset="49-59" id="DDI-PubMed.17524944.s13.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.17524944.s13.e0" e2="DDI-PubMed.17524944.s13.e0" /><pair ddi="false" e1="DDI-PubMed.17524944.s13.e0" e2="DDI-PubMed.17524944.s13.e1" /></sentence><sentence text=" Sirolimus metabolites showed a remarkably different pattern in children"><entity charOffset="1-10" id="DDI-PubMed.17524944.s14.e0" text="Sirolimus" /></sentence><sentence text=" Whereas 39-O-desmethyl sirolimus is the most prevalent metabolite in adults, we found 77"><entity charOffset="9-33" id="DDI-PubMed.17524944.s15.e0" text="39-O-desmethyl sirolimus" /></sentence><sentence text="5% hydroxylated metabolites in children" /><sentence text=" Similarly, pediatric human liver microsomes produced 86" /><sentence text="1% hydroxylated metabolites" /><sentence text="" /><sentence text="Our long-term objective is to develop evidence-based guidelines for age-appropriate drug dosing of all drugs commonly used during childhood and adolescence, based on pharmacokinetically/pharmacogenetically determined drug exposure to maximize therapeutic yield while minimizing toxicity" /><sentence text=" The potential need for lifelong medications warrants efforts to minimize toxicity in chronically ill pediatric patients" /><sentence text="" /></document>